Delivery Order SPE2DB20D2002-SPE2DB24FL62D
Award Date
6/18/24
Potential Completion Date
6/20/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,001.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S, with a performance period through May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,686.94 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. This is a one-time order with a completion date of June 26, 2024. The award is not associated with a larger contract vehicle. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,337.67 delivery order contract is a Firm Fixed Price type with a completion date of September 22, 2023. The contract provides the DLA with the pharmaceutical product "XULANE 150-35 MCG/DAY PATCH 3S". This award does not have a set-aside designation, indicating open competition. Amerisourcebergen also...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,456.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug...
This federal contract award is for the delivery of pharmaceutical products, specifically XULANE 150-35 MCG/DAY PATCH 3S, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,224.18 and has an Ultimate Completion Date of February 13, 2025. This award is not associated with a set-aside designation, indicating open...
This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,478.97, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 18, 2024. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order with a firm fixed price of $1,159.08 and a completion date of March 5, 2025. The award was made by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award, valued at $2,385.24, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2024 and a firm fixed price pricing type. This contract was not set aside for any specific business type. Amerisourcebergen Drug...
This federal contract award is for the delivery of the pharmaceutical product XULANE 150-35 MCG/DAY PATCH 3S to the Defense Logistics Agency (DLA). The contract, valued at $1,059.88, was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is a delivery order contract with a firm fixed price, and the ultimate completion date is June 21, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,817.16 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription medication. The contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...